HRTX - Heron Therapeutics GAAP EPS of -$0.17 beats by $0.15 revenue of $30.03M beats by $2.79M
2023-03-23 16:06:31 ET
- Heron Therapeutics press release ( NASDAQ: HRTX ): Q4 GAAP EPS of -$0.17 beats by $0.15 .
- Revenue of $30.03M (+45.4% Y/Y) beats by $2.79M .
- As of December 31, 2022, Heron had cash, cash equivalents and short-term investments of $84.9 million, compared to $157.6 million as of December 31, 2021.
- Shares +7.99% .
For further details see:
Heron Therapeutics GAAP EPS of -$0.17 beats by $0.15, revenue of $30.03M beats by $2.79M